EA200401350A1 - Способ получения комбретастатинов - Google Patents

Способ получения комбретастатинов

Info

Publication number
EA200401350A1
EA200401350A1 EA200401350A EA200401350A EA200401350A1 EA 200401350 A1 EA200401350 A1 EA 200401350A1 EA 200401350 A EA200401350 A EA 200401350A EA 200401350 A EA200401350 A EA 200401350A EA 200401350 A1 EA200401350 A1 EA 200401350A1
Authority
EA
Eurasian Patent Office
Prior art keywords
combrestastinins
producing
phosphonium salt
wittig
nitrometoxybenzyl
Prior art date
Application number
EA200401350A
Other languages
English (en)
Other versions
EA007965B1 (ru
Inventor
Стефан Мютти
Мишель Лавинь
Ирина Малежонок
Жан-Поль Казимир
Original Assignee
Авентис Фарма С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Авентис Фарма С.А. filed Critical Авентис Фарма С.А.
Publication of EA200401350A1 publication Critical patent/EA200401350A1/ru
Publication of EA007965B1 publication Critical patent/EA007965B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/02—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions involving the formation of amino groups from compounds containing hydroxy groups or etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/78—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C217/80—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings
    • C07C217/82—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring
    • C07C217/84—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring the oxygen atom of at least one of the etherified hydroxy groups being further bound to an acyclic carbon atom
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

Настоящее изобретение относится к новым способам получения комбретастатинов путем конденсации по способу Виттига нитрометоксибензальдегида и фосфониевой соли триметоксибензила или, наоборот, фосфониевой соли нитрометоксибензила и триметоксибензальдегида или путем реакции Виттига между этими же производными, в которых нитрогруппа восстановлена до аминогруппы.Отчет о международном поиске был опубликован 2004.04.08.
EA200401350A 2002-04-11 2003-04-09 Способ получения комбретастатинов EA007965B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0204499A FR2838437B1 (fr) 2002-04-11 2002-04-11 Procedes de preparation de combretastatines
PCT/FR2003/001117 WO2003084919A2 (fr) 2002-04-11 2003-04-09 Procedes de preparation de combretastatines

Publications (2)

Publication Number Publication Date
EA200401350A1 true EA200401350A1 (ru) 2005-02-24
EA007965B1 EA007965B1 (ru) 2007-02-27

Family

ID=28459732

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200401350A EA007965B1 (ru) 2002-04-11 2003-04-09 Способ получения комбретастатинов

Country Status (28)

Country Link
EP (3) EP2348012A1 (ru)
JP (1) JP4299677B2 (ru)
KR (1) KR101018983B1 (ru)
CN (1) CN1291970C (ru)
AR (2) AR039198A1 (ru)
AU (1) AU2003260026B2 (ru)
BR (1) BR0309087A (ru)
CA (1) CA2481742C (ru)
CR (1) CR7481A (ru)
EA (1) EA007965B1 (ru)
EC (1) ECSP045348A (ru)
FR (1) FR2838437B1 (ru)
HK (1) HK1075651A1 (ru)
HR (1) HRP20040935A2 (ru)
IL (1) IL164247A0 (ru)
MA (1) MA26407A1 (ru)
ME (1) MEP91508A (ru)
MX (1) MXPA04009112A (ru)
NO (2) NO329701B1 (ru)
NZ (1) NZ535318A (ru)
OA (1) OA12804A (ru)
PL (3) PL213967B1 (ru)
RS (3) RS20110562A3 (ru)
TN (1) TNSN04201A1 (ru)
TW (1) TWI262179B (ru)
UA (1) UA76079C2 (ru)
WO (1) WO2003084919A2 (ru)
ZA (1) ZA200407417B (ru)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7235688B1 (en) 2004-11-04 2007-06-26 University Of Notre Dame Du Lac Process for preparing histone deacetylase inhibitors and intermediates thereof
FR2928148B1 (fr) * 2008-02-28 2013-01-18 Sanofi Aventis Procede de preparation de combretastatine
FR2939665B1 (fr) 2008-12-12 2011-10-07 Sanofi Aventis Combinaison antitumorale associant l'ave8062a et le docetaxel
FR2945210B1 (fr) 2009-05-07 2011-07-01 Sanofi Aventis Combinaison antitumorale comprenant l'ave8062 et le sorafenib
FR2953518B1 (fr) 2009-12-03 2012-01-20 Sanofi Aventis Procede de preparation d'un derive de combretastatine
EP2397135A1 (en) 2010-06-18 2011-12-21 Sanofi An antitumoral combination comprising ombrabulin, a taxane derivative and a platinum derivative
CA2802974A1 (en) 2010-06-18 2011-12-22 Sanofi An antitumoral combination comprising ombrabulin, a taxane derivative and a platinum derivative
EP2481404A1 (en) 2010-11-15 2012-08-01 Sanofi An antitumoral combination comprising ombrabulin, a taxane derivative and a platinum derivative
EP2407161A1 (en) 2010-07-13 2012-01-18 Sanofi An antitumoral combination comprising ombrabulin and bevacizumab
FR2968557A1 (fr) 2010-12-09 2012-06-15 Sanofi Aventis Combinaison antitumorale comprenant un derive de la famille des combretastatines et le cetuximab
FR2978662A1 (fr) 2011-08-01 2013-02-08 Sanofi Sa Combinaison antitumorale comprenant l'ombrabuline et le cisplatine, associee a la radiotherapie
FR2978663A1 (fr) 2011-08-01 2013-02-08 Sanofi Sa Combinaison antitumorale comprenant l'ombrabuline et le cetuximab, associee a la radiotherapie
CN103012248B (zh) * 2013-01-11 2014-11-05 浙江大德药业集团有限公司 氨基康普立停衍生物的合成及其作为口服抗肿瘤药物的应用
EP3184095A1 (en) 2013-05-23 2017-06-28 IP Gesellschaft für Management mbH Administration units comprising polymorph 1 of 2-(2-methylamino-pyrimidin-4-yl]-1h-indole-5-carboxylic acid [(s)-1-carbamoyl-2-(phenyl-pyrimidin-2-yl-amino)-ethyl]-amide
EP4079327A1 (en) 2021-04-22 2022-10-26 Centaurus Polytherapeutics Payloads for drug-conjugates and their use for treating cancer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4996237A (en) 1987-01-06 1991-02-26 Arizona Board Of Regents Combretastatin A-4
UA18265A (ru) * 1988-02-24 1997-12-25 Ф.Хоффманн-Ля Рош Аг Способ получения производных стильбеhа
NZ232897A (en) * 1989-04-03 1992-12-23 Squibb & Sons Inc Interphenylene 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogues, preparation and pharmaceutical compositions thereof
US5731353A (en) * 1993-09-08 1998-03-24 Ajinomoto Co., Inc. Stilbene derivatives and pharmaceutical compositions containing them
TW325458B (en) 1993-09-08 1998-01-21 Ajinomoto Kk Stilbene derivatives and pharmaceutical compositions comprising the same for anti-cancer
PT754682E (pt) * 1994-04-06 2002-03-28 Nippon Shinyaku Co Ltd Derivado de aminostilbazol e medicamento
TW334418B (en) * 1995-03-07 1998-06-21 Ajinomoto Kk Stilbene derivatives and pharmaceutical compositions
JP4551514B2 (ja) * 1999-07-23 2010-09-29 住友化学株式会社 不飽和炭化水素残基置換アニリン類の製造方法
GB9918912D0 (en) 1999-08-12 1999-10-13 Angiogene Pharm Ltd New stilbenes with vascular damaging activity

Also Published As

Publication number Publication date
FR2838437A1 (fr) 2003-10-17
RS20110562A2 (en) 2012-10-31
NO329701B1 (no) 2010-12-06
CN1291970C (zh) 2006-12-27
RS20110562A3 (en) 2013-12-31
CR7481A (es) 2008-11-25
PL213708B1 (pl) 2013-04-30
RS20110561A2 (en) 2012-10-31
OA12804A (fr) 2006-07-11
PL371629A1 (en) 2005-06-27
PL213967B1 (pl) 2013-05-31
TWI262179B (en) 2006-09-21
AR039198A1 (es) 2005-02-09
BR0309087A (pt) 2005-02-09
MXPA04009112A (es) 2004-12-07
KR101018983B1 (ko) 2011-03-07
TW200401762A (en) 2004-02-01
MEP91508A (en) 2011-12-20
WO2003084919A2 (fr) 2003-10-16
MA26407A1 (fr) 2004-12-01
RS20110561A3 (en) 2013-10-31
UA76079C2 (en) 2006-06-15
CA2481742A1 (fr) 2003-10-16
HRP20040935A2 (en) 2005-10-31
EA007965B1 (ru) 2007-02-27
HK1075651A1 (en) 2005-12-23
CN1646476A (zh) 2005-07-27
ECSP045348A (es) 2004-11-26
NO331372B1 (no) 2011-12-12
AR082581A2 (es) 2012-12-19
PL394821A1 (pl) 2011-09-12
TNSN04201A1 (fr) 2007-03-12
ZA200407417B (en) 2006-04-26
JP4299677B2 (ja) 2009-07-22
EP1497255A2 (fr) 2005-01-19
RS52331B (en) 2012-12-31
PL214129B1 (pl) 2013-06-28
NZ535318A (en) 2007-02-23
WO2003084919A3 (fr) 2004-04-08
PL394820A1 (pl) 2011-09-12
JP2005522478A (ja) 2005-07-28
KR20040108717A (ko) 2004-12-24
AU2003260026A1 (en) 2003-10-20
FR2838437B1 (fr) 2004-06-04
NO20044814L (no) 2004-01-07
AU2003260026B2 (en) 2008-01-03
EP2348012A1 (fr) 2011-07-27
RS86504A (en) 2007-02-05
CA2481742C (fr) 2012-06-19
NO20101215L (no) 2004-01-07
IL164247A0 (en) 2005-12-18
EP2354118A1 (fr) 2011-08-10

Similar Documents

Publication Publication Date Title
EA200401350A1 (ru) Способ получения комбретастатинов
EA200400368A1 (ru) Новые дигидроптеридиноны, способы их получения и их применение в качестве лекарственных средств
FI971312A (fi) Uudet prostaglandiinisyntaasin estäjät
BR0312121A (pt) xinalases, ácidos nucléicos codificando-as e métodos para preparar e empregá-las
ATE501126T1 (de) Verfahren zur herstellung von rosuvastatin
BR0209984A (pt) Processo para a preparação de prostaglandinas e seus análogos
CY1107681T1 (el) Χρηση παραγωγων τροπινεστερα για την παραγωγη φαρμακευτικων μεσων
MX2007007446A (es) Procesos para la produccion de 4-aminoquinazolinas.
UY27606A1 (es) Inhibidores de la fosfarasa
EA200400487A1 (ru) Фармацевтическая композиция длительного высвобождения, содержащая метформин
NO20040388L (no) Fremgangsmåte for fremstilling av beraprost og salter derav, samt forbindelser som er mellomprodukter i fremgangsmåten
DE69912474D1 (de) Verfahren zur racematspaltung von tramadol
ATE457972T1 (de) Verfahren zur herstellung von 7-amino-syn-3,5- dihydroxyheptansäurederivaten und zwischenverbindungen diesesverfahrens und deren herestellung
BR0213779A (pt) Molécula de ácido nucleico isolada, vetor, célula hospedeira, e, método para a preparação de um composto de quìmica fina
EA200501734A1 (ru) Способ получения (4-гидрокси-6-оксотетрагидропиран-2-ил)ацетонитрила и его производных
ATE387425T1 (de) Verfahren zur herstellung von bicalutamid
HUP0401916A2 (hu) Eljárás fenolos vegyületek nitrálására
EA200701862A1 (ru) Улучшенный способ очистки периндоприла
EA200000924A2 (ru) СПОСОБ ПОЛУЧЕНИЯ ПИРАЗОЛО[4,3-d]ПИРИМИДИН-7-ОН-3-ПИРИДИЛСУЛЬФОНИЛЬНЫХ СОЕДИНЕНИЙ И ИХ ПРОМЕЖУТОЧНЫХ СОЕДИНЕНИЙ
NO20060816L (no) Fremgangsmate for fremstilling av a,B-umettede amidforbindelser
EA200000127A1 (ru) Способ получения аминопроизводных алкилоксифуранона, получаемые этим способом соединения и применение этих соединений
EA200600542A1 (ru) Способ для производства thip
HUP0104648A2 (hu) Eljárás polihalogénezett p-trifluorometil-anilinek előállítására
PT1317427E (pt) Processo para a producao de compostos quirais
EA199900282A2 (ru) Способ получения феноксифенилсульфонилгалогенидов

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU